Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions

NCT03041766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Schistosomiasis

Interventions

BIOLOGICAL: Sm14
DRUG: GLA-SE solution

Sponsor

Oswaldo Cruz Foundation

Collaborators

[object Object]
[object Object]
[object Object]